2023
DOI: 10.1039/d3ce00853c
|View full text |Cite
|
Sign up to set email alerts
|

Chiral resolution methods for racemic pharmaceuticals based on cocrystal formation

Raha Kaviani,
Abolghasem Jouyban,
Ali Shayanfar

Abstract: Nowadays, more than half of available drugs on the market are chiral, and approximately 90% of these drugs are sold as racemates. When these racemic medications are exposed to the...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 73 publications
(146 reference statements)
0
0
0
Order By: Relevance
“…In this context, cocrystallization has been shown to be a particularly powerful and diverse tool, with several methodologies successfully introduced in the last decade. 6 Springuel et al set the stage introducing chiral resolution through enantiospecific cocrystallization (Scheme 1, eqn (4)), focusing on resolving etiracetam using S -mandelic acid. 7 Only the cocrystal with the S -enantiomer of the target forms, which emphasizes the difference with respect to diastereomeric salt resolution.…”
mentioning
confidence: 99%
“…In this context, cocrystallization has been shown to be a particularly powerful and diverse tool, with several methodologies successfully introduced in the last decade. 6 Springuel et al set the stage introducing chiral resolution through enantiospecific cocrystallization (Scheme 1, eqn (4)), focusing on resolving etiracetam using S -mandelic acid. 7 Only the cocrystal with the S -enantiomer of the target forms, which emphasizes the difference with respect to diastereomeric salt resolution.…”
mentioning
confidence: 99%